Company / EPS (Diluted)
Erasca, Inc. EPS (Diluted) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.69
FY2024
5-year range
-$1.99 / -$0.69
FY2021-FY2024
Trend
+16.9%
vs FY2023
Sector context
#76 of 204
Health Care
What the data says
At $-0.69, Erasca, Inc.'s eps (diluted) ranks #76 of 204 in the Health Care sector. Improved from $-1.99 to $-0.69 over the past 2 years.
Based on SEC 10-K filings.
-0.69 in FY2024.
Improved from $-1.99 to $-0.69 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 204 in Health CareTop 37% of 204This company -$0.69 Sector average -$0.98
▼
+29.6% above sector average
Key checks
Key Insights
- In FY2024, eps (diluted) increased 16.9% year-over-year.
- Ranks #76 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.69 | +16.9% |
| FY2023 | -$0.83 | +58.3% |
| FY2022 | -$1.99 | -7.6% |
| FY2021 | -$1.85 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026